View in EDS

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.

Saved in:
Bibliographic Details
Title: An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
Authors: Stringer-Reasor EM; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., May JE; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Olariu E; Department of Medicine, Brookwood Baptist Health, Birmingham, AL, USA., Caterinicchia V; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Li Y; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Chen D; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Della Manna DL; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Rocque GB; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Vaklavas C; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Falkson CI; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Nabell LM; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Acosta EP; Department of Pharmacology/Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA., Forero-Torres A; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Yang ES; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. shyang@uabmc.edu.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, 1700 6th Avenue South, HSROC Suite 2232 (176F), Birmingham, AL, 35249, USA. shyang@uabmc.edu.
Source: Breast cancer research : BCR [Breast Cancer Res] 2021 Mar 04; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2021 Mar 04.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33663560
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stringer-Reasor+EM%22">Stringer-Reasor EM</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22May+JE%22">May JE</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Olariu+E%22">Olariu E</searchLink>; Department of Medicine, Brookwood Baptist Health, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Caterinicchia+V%22">Caterinicchia V</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Chen+D%22">Chen D</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Della+Manna+DL%22">Della Manna DL</searchLink>; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Rocque+GB%22">Rocque GB</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Vaklavas+C%22">Vaklavas C</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Falkson+CI%22">Falkson CI</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Nabell+LM%22">Nabell LM</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Acosta+EP%22">Acosta EP</searchLink>; Department of Pharmacology/Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Yang+ES%22">Yang ES</searchLink>; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. shyang@uabmc.edu.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, 1700 6th Avenue South, HSROC Suite 2232 (176F), Birmingham, AL, 35249, USA. shyang@uabmc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2021 Mar 04; Vol. 23 (1), pp. 30. <i>Date of Electronic Publication: </i>2021 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33663560
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-021-01408-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 30
    Titles:
      – TitleFull: An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor EM
      – PersonEntity:
          Name:
            NameFull: May JE
      – PersonEntity:
          Name:
            NameFull: Olariu E
      – PersonEntity:
          Name:
            NameFull: Caterinicchia V
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Chen D
      – PersonEntity:
          Name:
            NameFull: Della Manna DL
      – PersonEntity:
          Name:
            NameFull: Rocque GB
      – PersonEntity:
          Name:
            NameFull: Vaklavas C
      – PersonEntity:
          Name:
            NameFull: Falkson CI
      – PersonEntity:
          Name:
            NameFull: Nabell LM
      – PersonEntity:
          Name:
            NameFull: Acosta EP
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Yang ES
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 03
              Text: 2021 Mar 04
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1465-542X
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research : BCR
              Type: main
ResultId 1